Accretion Pharmaceuticals Limited

Accretion Pharmaceuticals Limited

SME NSE SME 100% Book Built Offer
Closed

Price Band

₹96 - ₹101

Total Issue

₹29.75 Cr

Bid Dates

14 May - 16 May

Subscription

7.15x

Est. GMP

₹0 (0.00%)

Website RHP Check Allotment

Tentative Timetable

Open
Close
Allotment
Refunds
Credit
Listing

Business Overview

Accretion Pharmaceuticals Limited is a pharmaceutical CDMO engaged in the manufacturing and marketing of a wide range of formulations including tablets, capsules, oral liquids, external preparations, and oral powders. The company operates through domestic sales, direct exports, and merchant exporter arrangements, with its products being supplied to several international markets through direct and indirect channels. With a strong focus on quality and compliance, the company caters to diverse client needs across geographies. Its operations are supported by a modern manufacturing facility and a dedicated team committed to excellence.

Lot Info

Lot Information for Accretion Pharmaceuticals IPO
Category Lots Shares Amount
Individual (Min) 1 1,200 ₹1,21,200
Individual (Max) 1 1,200 ₹1,21,200
S-HNI (Min) 2 2,400 ₹2,42,400
S-HNI (Max) 8 9,600 ₹9,69,600
B-HNI (Min) 9 10,800 ₹10,90,800
Market Maker
1,47,600 EQ Shares
Employee
₹0.00
Shareholder
₹0.00

Issue Size

Total ₹29.75 Cr
Fresh Issue
₹29.75 Cr (0.29 Cr Shares)
Offer For Sale
₹0.00 (0.00 Shares)

Objects of Issue

  1. Capital expenditure towards purchase of new equipment / machineries
  2. Capital expenditure towards upgradation of existing manufacturing facility
  3. Repayment of certain borrowings availed by our Company
  4. Funding working capital requirements
  5. General Corporate Purpose

Grey Market Premium

GMP ₹0
Est. Price ₹101
Est. Gain 0.00%

Accretion Pharmaceuticals IPO Peer Comparison

(Rs. in crores)

Accretion Pharmaceuticals IPO Peer Comparison Table
Particulars Accretion Pharma Sakar Healthcare Lincoln Pharmaceuticals Sotac Pharmaceuticals
Revenue from Ops (in Crs.) 33.67 153.35 580.55 67.11
PAT (In Crs.) 3.88 11.67 93.30 5.75
EPS - Basic 9.69 5.64 46.58 5.24
NAV per share 13.37 120.65 295.98 43.69
RONW 72.80% 4.45% 15.74% 11.91%
EBITDA 23.06% 26.47% 23.14% 17.16%
Price to earning (PE) 10.42 48.89 12.30 23.85
  • All the information pertains to FY 2023-24
  • The PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of May 05, 2025 for Peers

Financial Performance

(Rs. in crores)

Financial Performance Metrics for Accretion Pharmaceuticals IPO
Particulars Dec-24 Mar-24 Mar-23 Mar-22
Revenue from Operations 35.67 33.67 29.38 22.29
Profit after Tax 5.24 3.88 0.10 0.08
Net Worth 13.58 5.35 3.84 3.08
Total Borrowing 13.79 13.48 8.47 7.61
Total Assets 39.99 27.05 20.58 17.74
NAV per share (in ₹) 17.09 13.37 NA NA
EPS - Basic (in ₹) 8.74 9.69 NA NA

KPIs

EBITDA

23.06%

PAT

11.51%

ROE

72.80%

ROCE

36.73%

PE Ratio

10.42

PB Ratio

7.55

Mkt Cap (in Crs.)

112.27

  • All Ratios are based on Mar 24
  • PE, PB, and Post-Issue Market Capitalization are calculated based on the upper price band.

Shareholding

Promoter

3.72%

Public

96.28%

Mayur Popatlal Sojitra 24.07%
HarshadNanubhaiRathod 24.07%
Vivek Ashok Kumar Patel 24.07%
Hardik Mukundbhai Prajapati 24.07%

Management

Vivek Ashok Kumar Patel MD
Harshad Nanubhai Rathod CFO

Registrar & Lead Managers

Lead Managers (1)

Subscription Status

Updated as on 16-May-2025 19:00:05 hrs

Category Sub (x) Offered Bids
QIB 4.87x 3,52,800 17,19,600
NII 4.41x 12,22,800 53,91,600
Individual Investor 10.55x 12,22,800 1,28,95,200
Total 7.15x 27,98,400 2,00,06,400

Frequently Asked Questions

What is Accretion Pharmaceuticals IPO?
Accretion Pharmaceuticals IPO is a SME IPO having an issue size of ₹29.75 Crs. Accretion Pharmaceuticals IPO is priced at ₹96 - ₹101 per share. The issue opens on 14 May 25 and closes on 16 May 25.
When will Accretion Pharmaceuticals IPO open?
Accretion Pharmaceuticals IPO opens on 14 May 25 and closes on 16 May 25.
What is the GMP of Accretion Pharmaceuticals IPO?
The estimated Grey Market Premium of Accretion Pharmaceuticals IPO is ₹0 per share (0.00%).
What is the lot size of Accretion Pharmaceuticals IPO?
The minimum lot size of Accretion Pharmaceuticals IPO is 1200 shares & the minimum application amount is Rs. 121200.
When is the allotment of Accretion Pharmaceuticals IPO?
The allotment date of Accretion Pharmaceuticals IPO is 19 May 25.
What is the listing date of Accretion Pharmaceuticals IPO?
The listing date of Accretion Pharmaceuticals IPO is 21 May 25.
What is the subscription of Accretion Pharmaceuticals IPO?
Accretion Pharmaceuticals IPO is subscribed 7.15 times.
What is the price band of Accretion Pharmaceuticals IPO?
Accretion Pharmaceuticals IPO is priced at ₹96 - ₹101 per share.
How to check allotment status of Accretion Pharmaceuticals IPO?
Click the allotment link on Accretion Pharmaceuticals IPO page of IPO360.
How to apply Accretion Pharmaceuticals IPO in Zerodha?
  1. Go to Kite App → Tap on Bids → Tap on IPO
  2. Select the IPO → Tap on apply → Enter UPI ID
  3. Enter Qty and Price
  4. Submit the application
  5. Approve the UPI Mandate on your UPI app
How to apply Accretion Pharmaceuticals IPO in Groww?
  1. Go to Groww App → Stocks Section → Select IPO option
  2. Select the IPO you want to apply
  3. Enter your bid details and price
  4. Enter UPI ID & submit
  5. Approve the UPI Mandate on your UPI app
How to apply Accretion Pharmaceuticals IPO using ASBA?
  1. Log in to your bank's net banking portal.
  2. Navigate to the 'IPO' or 'ASBA' section.
  3. Select Accretion Pharmaceuticals IPO from the list of available IPOs.
  4. Enter the required details: Bid quantity, Price, DP ID & Client ID, etc
  5. Submit the application.
  6. Money will remain blocked till the refund date